Studies Assess Genetic Testing Trends, Both DTC And Physician-Prescribed
This article was originally published in The Gray Sheet
Executive Summary
Two studies that came out last week take a look at factors driving acceptance and adoption of genetic testing among consumers and physicians.
You may also be interested in...
Medco's Personalized Medicine Focus Includes SureGene Dx Development
Medco will launch a research project in November in collaboration with genetic test developer SureGene to validate a biomarker that may improve the cost effectiveness of atypical antipsychotic drug treatment. The SureGene pact was announced Aug. 24
'We Should Have Acted Sooner' On DTC Gene Tests, Shuren Tells Lawmakers
CDRH has been busy for the past two months in an effort to bring direct-to-consumer genetic test services into its regulatory fold, but Center Director Jeff Shuren acknowledged to a House subcommittee last week that the agency was slow to tackle the matter
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.